Explain this page
Arphra AIPlain-English read on Loews Corporation’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Quality composite
BMixed
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Profitability
Gross margin43.9%
Operating margin12.6%
Net margin9.2%
ROE8.5%
ROA1.9%
ROIC6.2%
Liquidity & leverage
Current ratio0.48×
Quick ratio0.48×
Debt / equity0.48×
Net debt / EBITDA2.70×
Interest coverage5×
Efficiency & per-share
Asset turnover0.21×
Inventory days0
Days sales out.220
FCF / share$12.91
Book value / share$93.93
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E |
|---|---|---|---|---|---|---|
| Headline | ||||||
| Market cap | — | — | — | $18.65B | $22.02B | — |
| Enterprise value | — | — | — | $27.06B | $31.01B | — |
| Multiples | ||||||
| P / E | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — |
| EV / Sales | — | — | — | 1.57 | 1.71 | — |
| EV / FCF | — | — | — | 11.31 | 11.49 | — |
| Yields | ||||||
| Earnings yield | — | — | — | +7.58% | +7.57% | — |
| Free cash flow yield | — | — | — | +12.83% | +12.26% | — |
| Dividend yield | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross margin | +43.08% | +42.04% | +44.43% | +44.68% | +43.93% | +43.12% |
| Operating margin | +15.74% | +7.93% | +12.73% | +10.87% | +12.56% | +12.03% |
| EBITDA margin | +22.58% | +14.24% | +18.56% | +16.81% | +18.32% | +17.68% |
| EBIT margin | +18.82% | +10.62% | +15.13% | +13.43% | +14.96% | +14.73% |
| Pre-tax margin | +15.74% | +7.93% | +12.73% | +10.87% | +12.56% | +12.40% |
| Net margin | +11.38% | +5.85% | +9.15% | +8.20% | +9.17% | +8.61% |
| Cost structure | ||||||
| Cost of revenue / sales | +56.92% | +57.96% | +55.57% | +55.32% | +56.07% | +54.10% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Effective tax rate | +21.99% | +20.02% | +22.60% | +20.28% | +22.38% | +21.33% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E |
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity (ROE) | +8.15% | +5.41% | +8.68% | +7.88% | +8.49% | +8.33% |
| Return on assets (ROA) | +1.91% | +1.09% | +1.81% | +1.73% | +1.93% | +1.79% |
| Return on capital (ROC) | +7.64% | +4.60% | +7.82% | +6.97% | +7.84% | +7.69% |
| Return on invested capital (ROIC) | +5.53% | +3.39% | +5.62% | +5.26% | +5.72% | +5.50% |
| Asset turnover | +16.82% | +18.59% | +19.80% | +21.04% | +21.05% | +20.75% |
| DuPont · ROE decomposition | ||||||
| Net margin | +11.38% | +5.85% | +9.15% | +8.20% | +9.17% | +8.61% |
| Asset turnover (× revenue / assets) | +16.82% | +18.59% | +19.80% | +21.04% | +21.05% | +20.75% |
| Equity multiplier (× assets / equity) | +425.69% | +497.12% | +479.26% | +456.84% | +439.63% | +466.16% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Asset turnover | 0.17 | 0.19 | 0.20 | 0.21 | 0.21 | 0.21 |
| Fixed-asset turnover | 1.39 | 1.40 | 1.46 | 1.61 | 1.70 | — |
| Inventory turnover | — | — | — | — | — | — |
| Receivables turnover | 1.54 | 1.49 | 1.62 | 1.64 | 1.66 | — |
| Payables turnover | 86.82 | 61.23 | 110.28 | 86.69 | 192.30 | — |
| Days outstanding | ||||||
| Days sales outstanding (DSO) | 236.54 | 244.28 | 224.89 | 222.59 | 220.49 | — |
| Days inventory outstanding (DIO) | — | — | — | — | — | — |
| Days payables outstanding (DPO) | 4.20 | 5.96 | 3.31 | 4.21 | 1.90 | — |
| Cash conversion cycle | 232.34 | 238.32 | 221.58 | 218.38 | 218.60 | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E |
|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.68 | 4.03 | 2.72 | 2.14 | 1.97 | 2.39 |
| FCF / Net income | 1.37 | 3.23 | 2.25 | 1.69 | 1.62 | 1.86 |
| FCF margin | +15.60% | +18.89% | +20.54% | +13.88% | +14.85% | +15.98% |
| OCF margin | +19.11% | +23.59% | +24.92% | +17.55% | +18.04% | +20.60% |
| CapEx / Revenue | +3.51% | +4.70% | +4.38% | +3.67% | +3.19% | +3.75% |
| CapEx / D&A | 0.94 | 1.30 | 1.28 | 1.08 | 0.95 | — |
| Stock-based comp / Revenue | 0.00% | 0.00% | +0.23% | 0.00% | 0.00% | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E |
|---|---|---|---|---|---|---|
| EPS · diluted | 6.00 | 3.38 | 6.29 | 6.41 | 7.97 | 0.00 |
| EPS · basic | 6.02 | 3.39 | 6.30 | 6.42 | 7.97 | 0.00 |
| Book value / share | 73.69 | 62.48 | 72.54 | 81.34 | 93.93 | 107.83 |
| Tangible BV / share | 71.93 | 57.29 | 66.42 | 75.41 | 87.55 | 107.83 |
| Sales / share | 52.76 | 57.75 | 68.82 | 78.17 | 86.92 | 104.32 |
| Operating CF / share | 10.08 | 13.62 | 17.15 | 13.72 | 15.68 | 21.49 |
| Free cash flow / share | 8.23 | 10.91 | 14.14 | 10.85 | 12.91 | 16.67 |
| Dividends / share | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.34 |
| Payout ratio | +4.16% | +7.42% | +3.97% | +3.89% | +3.12% | +3.79% |
| Retention ratio | +95.84% | +92.58% | +96.03% | +96.11% | +96.88% | +96.21% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 5y CAGR |
|---|---|---|---|---|---|---|---|
| Top-line | |||||||
| Revenue · YoY | — | +2.35% | +11.59% | +9.96% | +5.44% | +20.51% | +9.80% |
| Gross profit · YoY | — | -0.10% | +17.93% | +10.58% | +3.65% | +18.28% | +9.82% |
| Profit | |||||||
| Operating income · YoY | — | -48.43% | +79.17% | -6.11% | +21.82% | +15.46% | +4.06% |
| EBITDA · YoY | — | -35.43% | +45.43% | -0.41% | +14.91% | +16.30% | +4.56% |
| Net income · YoY | — | -47.38% | +74.45% | -1.39% | +17.89% | +13.08% | +3.83% |
| Operating | |||||||
| EBIT · YoY | — | -42.26% | +58.98% | -2.40% | +17.49% | +18.65% | +4.55% |
| R&D · YoY | — | — | — | — | — | — | — |
| Per-share | |||||||
| EPS · diluted · YoY | — | -43.67% | +86.09% | +1.91% | +24.34% | -100.00% | — |
| EPS · basic · YoY | — | -43.69% | +85.84% | +1.90% | +24.14% | -100.00% | — |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E |
|---|---|---|---|---|---|---|
| Leverage | ||||||
| Total debt | $9.08B | $9.02B | $9B | $8.94B | $9.49B | $11.65B |
| Net debt | $8.46B | $8.49B | $8.6B | $8.4B | $8.99B | $11.06B |
| Net debt / EBITDA | 2.73 | 4.24 | 2.96 | 2.90 | 2.70 | 2.86 |
| Debt / equity | 0.47 | 0.59 | 0.54 | 0.50 | 0.48 | 0.51 |
| Debt / assets | +11.12% | +11.94% | +11.37% | +10.91% | +10.99% | +11.04% |
| Equity / assets | +23.49% | +20.12% | +20.87% | +21.89% | +22.75% | +21.45% |
| Coverage | ||||||
| EBITDA / interest expense | 7.31 | 5.29 | 7.74 | 6.57 | 7.62 | 7.35 |
| Operating income / interest | 5.09 | 2.95 | 5.31 | 4.25 | 5.22 | 5.00 |
| Interest expense | $424M | $378M | $376M | $441M | $437M | $526.69M |
| Liquidity | ||||||
| Current ratio | — | 1.52 | 0.43 | 0.48 | 0.48 | — |
| Quick ratio | — | 1.52 | 0.43 | 0.48 | 0.48 | — |
| Cash ratio | — | 0.02 | 0.01 | 0.01 | 0.01 | — |
| Working capital | $0 | $18.05B | -$20.75B | -$19.34B | -$20.78B | — |
| Working capital / revenue | 0.00% | +128.46% | -132.32% | -112.18% | -114.30% | — |
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
Valuation
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| P / E | — | — |
| P / B | — | — |
| EV / EBITDA | — | — |
| EV / Sales | 1.71x | 1.57x |
| Earnings yield | 7.6% | 7.6% |
| FCF yield | 12.3% | 12.8% |
Returns
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
| ROE | 8.9% | 8.3% |
| ROA | 1.9% | 1.7% |
| ROIC | 3.8% | 3.4% |
Leverage & liquidity
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Debt / equity | — | — |
| Net debt / EBITDA | 2.70 | 2.90 |
| Interest coverage | — | — |
| Current ratio | 0.48x | 0.48x |
| Quick ratio | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).